Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1093/ajcp/aqab210

http://scihub22266oqcxt.onion/10.1093/ajcp/aqab210
suck pdf from google scholar
34919640!8755306!34919640
unlimited free pdf from europmc34919640    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid34919640      Am+J+Clin+Pathol 2022 ; 157 (6): 844-851
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • COVID-19 and Immune-Mediated RBC Destruction #MMPMID34919640
  • Jacobs JW; Booth GS
  • Am J Clin Pathol 2022[Jun]; 157 (6): 844-851 PMID34919640show ga
  • OBJECTIVES: To summarize the epidemiologic, clinical, and laboratory characteristics of autoimmune hemolytic anemia (AIHA) secondary to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or vaccination. METHODS: We conducted a systematic review using standardized keyword search to identify all reports of SARS-CoV-2 infection or vaccination and AIHA across PubMed, Web of Science, Scopus, and Google Scholar through September 24, 2021. RESULTS: Fifty patients (mean [SD] age, 50.8 [21.6] years) diagnosed with coronavirus disease 2019 (COVID-19) and AIHA were identified. AIHA subtypes and number of patients were as follows: cold AIHA (n = 18), warm AIHA (n = 14), mixed-type AIHA (n = 3), direct antiglobulin test (DAT)-negative AIHA (n = 1), DAT-negative Evans syndrome (n = 1), Evans syndrome (n = 3), and subtype not reported (n = 10). Mean (SD) hemoglobin at AIHA diagnosis was 6.5 [2.8] g/dL (95% confidence interval, 5.7-7.3 g/dL). Median time from COVID-19 symptom onset to AIHA diagnosis was 7 days. In total, 19% (8/42) of patients with COVID-19-associated AIHA with reported outcomes were deceased. Four patients (mean [SD] age, 73.5 [16.9] years) developed AIHA following SARS-CoV-2 vaccination: Pfizer-BioNTech BNT162b2 vaccine (n = 2); Moderna mRNA-1273 vaccine (n = 1); undisclosed mRNA vaccine (n = 1). AIHA occurred after 1 dose in 3 patients (median, 5 days). CONCLUSIONS: SARS-CoV-2 infection and vaccination are associated with multiple AIHA subtypes, beginning approximately 7 days after infectious symptoms and 5 days after vaccination.
  • |*COVID-19[MESH]
  • |*Vaccines[MESH]
  • |2019-nCoV Vaccine mRNA-1273[MESH]
  • |Aged[MESH]
  • |Anemia, Hemolytic, Autoimmune[MESH]
  • |BNT162 Vaccine[MESH]
  • |COVID-19 Vaccines[MESH]
  • |Humans[MESH]
  • |Middle Aged[MESH]
  • |SARS-CoV-2[MESH]
  • |Thrombocytopenia[MESH]
  • |Vaccines, Synthetic[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box